Biotech

Government research grants are a numbers game, but which states racked up the most impressive numbers in 2005? According to columnist Michael Rosen, the usual suspects - California, Massachusetts, and New York - remain atop the list, while companies in Wisconsin saw their share of...

Outspoken professors and unruly students capture many headlines, but some of the University of Wisconsin-Madison's most prominent graduates were reminded of what the university is doing in the areas of stem cell research, avian flu preparedness, and cyber security during a recent CEO summit of...

NimbleGen Systems, Inc., has improved its ability to sell microarray products to researchers worldwide by obtaining a non-exclusive, worldwide license to a number of patents held by Affymetrix, Inc. Affymetrix, which is based in Santa Clara, Calif., developed the first commercial microarray in 1994. ...

The war on flu, particularly the deadly avian flu, took a turn in the right direction with the recent discovery of a new compound at the University of Wisconsin-Madison, but the potential drug still faces a long road to approval. The compound may provide the...

Prior to a United States Patent and Trademark Office decision to review its controversial stem cell patents, the Wisconsin Alumni Research Foundation predicted such a review would take place. Now, WARF says it will prove the validity of the three patents, which are being challenged...

The Center for International Blood and Marrow Transplant Research (CIBMTR) of the Medical College of Wisconsin has entered into a $6 million contract to collect and maintain a standardized database of marrow and cord blood transplants performed in the United States. The CIBMTR collects outcome...

The state of Wisconsin and the Wisconsin Alumni Research Foundation have reached an agreement that could boost the state's biotechnology industry, giving Wisconsin a competitive advantage over states like California. However, a consumer watchdog group in the Golden State said the announcement is a tantamount...

ConjuGon, Inc., a Madison-based biopharmaceutical firm, has received a $730,000 Phase II Small Business Innovation Research grant from the U.S. Army to further develop its treatment for antibiotic-resistant bacterial infections. The company's efforts should help injured soldiers in Iraq and Afghanistan....

It takes two to tango, and the number of recent pharmaceutical mergers and acquisitions indicates that Big Pharma companies have had few problems finding dance partners. Michael Rosen's latest version of Yer Biotech Blues chronicles all these technological two-steps, and signals a changing of the...

An ethanol glue factory? The leftover residue from the ethanol production process may be more than just a by-product from which more ethanol can be produced, it might be used to produce a value-added product - glue - more affordably. If University of Wisconsin associated...